Hrsak I, Szirmai E
Arzneimittelforschung. 1979;29(1):44-8.
The effects of an 8-week treatment with the quinine-lithium-salicylate combination Togal and sole acetylsalicylic acid (ASA) on the hemopoietic bone marrow cells of mice were studied. In general, both substances caused only minor changes. A slight leukopenia caused by higher doses as well as a transitory erythropenia observed a little bit more distinctly in ASA treated animals than in Togal treated animals need more detailed discussion, especially so because after a short two-week Togal treatment some animals showed an increase of hemopoietic cell colonies which a sole ASA dose did not cause. On the other hand, these results indicate a lower toxicity of Togal in comparison with acetylsalicylic acid as has been already shown in several other publications. It was proven that after a several weeks' treatment with therapeutic doses no pernicious influence on blood producing organs or pathological processes of the blood picture occurred. Only doses that border on the toxic region lead to insignificant bone marrow changes. As these over-doses are ten times the highest therapeutical dose the use of Togal does any damage to the blood forming tissue or pathological changes in the blood count are not likely. This has also been proved by other authors by means of long-term tests on humans.
研究了奎宁 - 锂 - 水杨酸盐组合药物托加尔(Togal)和单独的乙酰水杨酸(ASA)对小鼠造血骨髓细胞进行为期8周治疗的效果。总体而言,这两种物质仅引起轻微变化。高剂量导致的轻度白细胞减少以及在接受ASA治疗的动物中比接受托加尔治疗的动物更明显观察到的短暂性红细胞减少,需要更详细的讨论,特别是因为在进行为期两周的托加尔治疗后,一些动物出现了造血细胞集落增加的情况,而单独使用ASA剂量并未导致这种情况。另一方面,这些结果表明与乙酰水杨酸相比,托加尔的毒性较低,这在其他一些出版物中已经有所显示。事实证明,在使用治疗剂量进行数周治疗后,对造血器官或血象的病理过程没有产生有害影响。只有接近毒性区域的剂量才会导致轻微的骨髓变化。由于这些过量剂量是最高治疗剂量的十倍,所以使用托加尔不太可能对造血组织造成任何损害或导致血象出现病理变化。其他作者通过对人体进行长期试验也证明了这一点。